Market Place
Sourcing Support
Enforcement Report - Week of April 17, 2024
17 Apr 2024 //
FDA
Mikart`s Generic Methocarbamol Receives Approval in the U.S.
12 Jun 2023 //
FDA
Lumirelax 10% cream: restrictions of use due to convulsions and allergic reactions
20 May 2022 //
FRANCAIS
Enforcement Report - Week of November 11, 2021
10 Nov 2021 //
FDA
Aurobindo Pharma`s Generic Methocarbamol Receives Approval in US
15 Aug 2020 //
FDA
Methocarbamol Injection, USP Now Available from Fresenius Kabi
12 Feb 2019 //
BUSINESSWIRE
Enforcement Report - Week of January 9, 2019
09 Jan 2019 //
FDA
Gland Pharma `s Generic Methocarbamol Receives Approval in US
01 Nov 2018 //
FDA
Enforcement Report - Week of October 10, 2018
10 Oct 2018 //
FDA
Endo Pharmaceuticals Voluntarily Recalls Robaxin Tablets
29 Sep 2018 //
FDA
Granules India’s Generic Methocarbamol Receives Approval In US
09 May 2018 //
FDA
Fresenius Kabi USA Generic Methocarbamol Receives Approval In US
20 Apr 2018 //
FDA
Navinta’s Generic Methocarbamol Receives Approval In US
28 Nov 2017 //
FDA
Beximco Pharm’s Generic Methocarbamol Receives Approval In US
21 Jul 2017 //
FDA
Sagent Pharm’s Generic Methocarbamol Receives Approval In US
18 Jul 2017 //
FDA
Enforcement Report - Week of July 12, 2017
12 Jul 2017 //
FDA
Luitpold Pharm’s Generic Methocarbamol Receives Approval In US
26 Jun 2017 //
FDA
Atlas Pharms LLC`s Generic Methocarbamol Receives Approval In US
08 Feb 2017 //
FDA
Renaissance`s Generic Methocarbamol Receives Approval In US
19 Jan 2017 //
FDA
Monterey Pharms` Generic Methocarbamol Received Approval In US
29 Oct 2016 //
FDA
Aurobindo`s Generic Methocarbamol approved in US as an Muscle relaxant
01 Jun 2016 //
FDA
Teva Canada recalls Equate-Muscle & Back Pain Relief
02 Feb 2016 //
HEALTH CANADA
Teva Canada recalls Biomedic-Muscle & Back Pain Relief
02 Feb 2016 //
HEALTH CANADA
Recall: Biomedic Muscle & Back Pain Relief - 8
02 Feb 2015 //
HEALTHY CANADIANS
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.